← United States · Coverage record
US · SEC FORM 4
Akari Therapeutics Plc
AKTX · Nasdaq · CIK 0001541157 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
29 Form 4 transaction lines observed in the same window
0 sales · 29 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-08-25 · Gaslightwala Abizer.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -18.0%
- 3M
- -23.7%
- 6M
- +86.1%
- 12M
- —
Volatility & liquidity
- Volatility
- 293.3%
- Beta
- —
- Avg daily value
- —
Valuation
- Market cap
- —
- P/E
- —
Fundamentals
- Profit margin
- —
- ROE
- -61.1%
- Industry
- Biotechnology
Market data
Price data up to: 2026-10-02 · Price source: OpenBB/yfinance · From SEC filings: ROE · Fiscal year ended: 2025-12-31 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 14,529
- Previous report
- 10,763
- Avg daily volume
- 62,368
- Days to cover
- ≤ 1.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-08-25 | Gaslightwala Abizer | Purchase (P) | American Depositary Shares representing Ordinary Shares | 3,000 | USD 0.90 | USD 2,700 | SEC filing ↗ |
| 2025-08-22 | Gaslightwala Abizer | Purchase (P) | American Depositary Shares representing Ordinary Shares | 8,000 | USD 0.93 | USD 7,440 | SEC filing ↗ |
| 2025-08-21 | Gaslightwala Abizer | Purchase (P) | American Depositary Shares representing Ordinary Shares | 10,000 | USD 0.94 | USD 9,400 | SEC filing ↗ |
| 2025-06-24 | Gaslightwala Abizer | Purchase (P) | American Depositary Shares representing Ordinary Shares | 5,203 | USD 1.16 | USD 6,035 | SEC filing ↗ |
| 2025-06-23 | Gaslightwala Abizer | Purchase (P) | American Depositary Shares representing Ordinary Shares | 943 | USD 1.15 | USD 1,084 | SEC filing ↗ |
| 2025-06-20 | Gaslightwala Abizer | Purchase (P) | American Depositary Shares representing Ordinary Shares | 10,000 | USD 1.20 | USD 12,000 | SEC filing ↗ |
| 2025-06-17 | Gaslightwala Abizer | Purchase (P) | American Depositary Shares representing Ordinary Shares | 15,000 | USD 1.20 | USD 18,000 | SEC filing ↗ |
Form 4 evidence
32 transaction lines in the latest 365-day window; 71 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Patel Sandip I | Option exercise / conversion (M) | American Depositary Shares representing Ordinary Shares | 10,052 | USD 0.00 | USD 4 | SEC filing ↗ |
| 2026-10-14 | Gaslightwala Abizer | Option exercise / conversion (M) | American Depositary Shares representing Ordinary Shares | 27,066 | USD 0.00 | USD 11 | SEC filing ↗ |
| 2026-10-14 | Bazemore Robert B | Option exercise / conversion (M) | American Depositary Shares representing Ordinary Shares | 3,866 | USD 0.00 | USD 2 | SEC filing ↗ |
Show recent Form 4 evidence (20 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Patel Sandip I | Option exercise / conversion (M) | American Depositary Shares representing Ordinary Shares | 10,052 | USD 0.00 | USD 4 | SEC filing ↗ |
| 2026-10-14 | Gaslightwala Abizer | Option exercise / conversion (M) | American Depositary Shares representing Ordinary Shares | 27,066 | USD 0.00 | USD 11 | SEC filing ↗ |
| 2026-10-14 | Bazemore Robert B | Option exercise / conversion (M) | American Depositary Shares representing Ordinary Shares | 3,866 | USD 0.00 | USD 2 | SEC filing ↗ |
| 2026-10-05 | Prudo-Chlebosz Raymond | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 3,240 | USD 7.90 | USD 25,593 | SEC filing ↗ |
| 2026-10-05 | Patel Sandip I | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 4,313 | USD 7.90 | USD 34,068 | SEC filing ↗ |
| 2026-10-05 | Patel Samir Rashmikant | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 2,236 | USD 7.90 | USD 17,662 | SEC filing ↗ |
| 2026-10-05 | Huh Hoyoung | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 6,160 | USD 7.90 | USD 48,658 | SEC filing ↗ |
| 2026-10-05 | Bazemore Robert B | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 4,677 | USD 7.90 | USD 36,944 | SEC filing ↗ |
| 2026-09-29 | Gaslightwala Abizer | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 6,430 | USD 9.72 | USD 62,500 | SEC filing ↗ |
| 2026-08-18 | Prudo-Chlebosz Raymond | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 9,072 | USD 7.90 | USD 71,660 | SEC filing ↗ |
| 2026-08-18 | Patel Sandip I | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 12,100 | USD 7.90 | USD 95,578 | SEC filing ↗ |
| 2026-08-18 | Patel Samir Rashmikant | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 6,300 | USD 7.90 | USD 49,764 | SEC filing ↗ |
| 2026-08-18 | Huh Hoyoung | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 17,249 | USD 7.90 | USD 136,250 | SEC filing ↗ |
| 2026-08-18 | Bazemore Robert B | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 13,100 | USD 7.90 | USD 103,477 | SEC filing ↗ |
| 2026-08-17 | Farag Kameel D. | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 1,728 | USD 7.52 | USD 12,995 | SEC filing ↗ |
| 2026-07-16 | Farag Kameel D. | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 1,130 | USD 11.50 | USD 12,995 | SEC filing ↗ |
| 2026-07-07 | Patel Samir Rashmikant | Option exercise / conversion (M) | American Depositary Shares representing Ordinary Shares | 22,474 | USD 0.43 | USD 9,672 | SEC filing ↗ |
| 2026-06-24 | Farag Kameel D. | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 18,830 | USD 5.58 | USD 105,006 | SEC filing ↗ |
| 2025-11-01 | Farag Kameel D. | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 58,619 | USD 0.75 | USD 43,964 | SEC filing ↗ |
| 2025-10-22 | Farag Kameel D. | Award / grant (A) | American Depositary Shares representing Ordinary Shares | 6,277 | USD 0.74 | USD 4,645 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | AKTX |
| CIK | 0001541157 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 71 transaction lines from 2024-04-26 to 2026-10-14 7 P purchase lines · 0 S sale lines · 64 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.